Aardvark Therapeutics, Inc. — All Filings
88 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-120164 | Mar 24, 2026 | Mar 23, 2026 |
| S-8 | S-8 | 0001193125-26-120120 | Mar 24, 2026 | — |
| S-3 | S-3 | 0001193125-26-119973 | Mar 23, 2026 | — |
| 10-K | 10-K | 0001193125-26-119770 | Mar 23, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-119727 | Mar 23, 2026 | — |
| 8-K | 8-K | 0001193125-26-082787 | Feb 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-047757 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | 4 | 0001193125-26-047317 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | 4 | 0001193125-26-047315 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | 4 | 0001193125-26-047316 | Feb 11, 2026 | Feb 9, 2026 |
| 8-K | 8-K | 0001193125-26-043764 | Feb 10, 2026 | — |
| 8-K | 8-K | 0001193125-26-009862 | Jan 12, 2026 | — |
| 4 | 4 | 0001193125-25-318070 | Dec 12, 2025 | Dec 11, 2025 |
| 4 | 4 | 0001193125-25-318069 | Dec 12, 2025 | Dec 11, 2025 |
| 8-K | 8-K | 0001193125-25-314364 | Dec 10, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-280260 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-280235 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-267402 | Nov 6, 2025 | Nov 5, 2025 |
| 8-K | 8-K | 0001193125-25-264748 | Nov 4, 2025 | — |
| 4 | 4 | 0001193125-25-241647 | Oct 16, 2025 | Oct 15, 2025 |
| 4 | 4 | 0001193125-25-241643 | Oct 16, 2025 | Oct 15, 2025 |
| 8-K | 8-K | 0001193125-25-234722 | Oct 9, 2025 | Oct 8, 2025 |
| 4 | 4 | 0001193125-25-204233 | Sep 16, 2025 | Sep 15, 2025 |
| 144 | — | 0001950047-25-007102 | Sep 15, 2025 | — |
| 4 | 4 | 0001193125-25-202490 | Sep 12, 2025 | Sep 10, 2025 |
| 4 | 4 | 0001193125-25-200226 | Sep 10, 2025 | Sep 9, 2025 |
| 8-K | 8-K | 0000950170-25-112645 | Sep 3, 2025 | Sep 2, 2025 |
| 144 | — | 0001950047-25-006593 | Sep 2, 2025 | — |
| 4 | 4 | 0001193125-25-192747 | Aug 29, 2025 | Aug 28, 2025 |
| 144 | — | 0001950047-25-006518 | Aug 28, 2025 | — |
| S-8 | S-8 | 0000950170-25-108176 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-108116 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-108082 | Aug 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-107320 | Aug 12, 2025 | — |
| 4 | 4 | 0000950170-25-086147 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086146 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086145 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086141 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086140 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086143 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086139 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-086138 | Jun 13, 2025 | Jun 11, 2025 |
| SCHEDULE 13G | — | 0000950170-25-072801 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-071560 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-071477 | May 14, 2025 | — |
| 10-K | 10-K | 0000950170-25-047835 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-047769 | Mar 31, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-016592 | Feb 24, 2025 | — |
| SCHEDULE 13G | — | 0001415889-25-005246 | Feb 24, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-016266 | Feb 24, 2025 | — |